Investors Interested in Being a Lead Plaintiff in Securities Fraud Class Action Lawsuit Against Provention Bio – Contact Johnson Fistel

SAN DIEGO, July 6, 2021 (GLOBE NEWSWIRE) – Shareholder rights law firm Johnson Fistel, LLP announces that it has filed a class action lawsuit on behalf of investors of Provention Bio, Inc. (NASDAQ: PRVB) (“Provention” or the “Company “). The class action is on behalf of shareholders, the provenance between November 2, 2020 – April 8, 2021 including both dates (the “Class Period”). If you want to appear as the lead plaintiff in this class action, you must go to court no later than July 20, 2021.

[click here to join this action]

The complaint filed alleges that defendants made materially false and / or misleading information and / or failed to disclose: (i) the Teplizumab Biologics License Application (“BLA”) was flawed as filed and would require additional data need to get US Food and Drug Agency approval; (ii) accordingly, teplizumab BLA lacked the conclusive support that the Company believed investors would provide; (iii) the Company had overestimated the prospect of approval for teplizumab BLA and thus the timeline for commercializing teplizumab; and (iv) as a result, the Company’s public statements at all relevant times have been materially false and misleading.

A lead plaintiff will act on behalf of all other class plaintiffs in leading the class action against prevention. The lead plaintiff can choose a law firm of their choice to bring the class action lawsuit. An investor’s ability to participate in a potential future collection of the class action lawsuit against prevention does not depend on being the lead plaintiff.

If you are a Provention shareholder and you are at a loss and want to learn more about how you can be a lead plaintiff, please contact Jim Baker ([email protected]) at the 619-814-4471. Please include your telephone number in your email.

Besides, you can [click here to join this action]. There are no costs or obligations for you.

About Johnson Fistula, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents private and institutional investors in shareholder derivative and securities class actions. More information about the firm and their attorneys can be found at http://www.johnsonfistel.com. Lawyer advertising. Past results do not guarantee future results.

The story goes on

Contact:
Johnson Fistula, LLP
Jim Baker, 619-814-4471
[email protected]

Comments are closed.